Monte Rosa Therapeutics Inc (GLUE)
Monte Rosa Therapeutics Market Cap: 261.15M for May 20, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 17, 2024 | 262.66M |
May 16, 2024 | 263.67M |
May 15, 2024 | 264.18M |
May 14, 2024 | 252.56M |
May 13, 2024 | 250.03M |
May 10, 2024 | 244.98M |
May 09, 2024 | 261.65M |
May 08, 2024 | 265.69M |
May 07, 2024 | 286.91M |
May 06, 2024 | 290.95M |
May 03, 2024 | 284.34M |
May 02, 2024 | 281.82M |
May 01, 2024 | 298.93M |
April 30, 2024 | 267.73M |
April 29, 2024 | 282.32M |
April 26, 2024 | 268.23M |
April 25, 2024 | 274.27M |
April 24, 2024 | 275.28M |
April 23, 2024 | 278.80M |
April 22, 2024 | 276.79M |
April 19, 2024 | 294.40M |
April 18, 2024 | 297.93M |
April 17, 2024 | 291.89M |
April 16, 2024 | 304.21M |
April 15, 2024 | 329.82M |
Date | Value |
---|---|
April 12, 2024 | 361.94M |
April 11, 2024 | 359.94M |
April 10, 2024 | 359.94M |
April 09, 2024 | 394.57M |
April 08, 2024 | 377.00M |
April 05, 2024 | 354.92M |
April 04, 2024 | 352.91M |
April 03, 2024 | 347.89M |
April 02, 2024 | 341.36M |
April 01, 2024 | 358.43M |
March 28, 2024 | 353.59M |
March 27, 2024 | 353.08M |
March 26, 2024 | 330.52M |
March 25, 2024 | 424.30M |
March 22, 2024 | 386.69M |
March 21, 2024 | 380.67M |
March 20, 2024 | 373.65M |
March 19, 2024 | 347.07M |
March 18, 2024 | 336.03M |
March 15, 2024 | 321.49M |
March 14, 2024 | 305.44M |
March 13, 2024 | 333.52M |
March 12, 2024 | 304.94M |
March 11, 2024 | 311.96M |
March 08, 2024 | 315.38M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
Biogen Inc | 33.62B |
Ionis Pharmaceuticals Inc | 5.440B |
CEL-SCI Corp | 70.41M |
AIM ImmunoTech Inc | 20.95M |
IGC Pharma Inc | 35.05M |
Market Cap Related Metrics
Price to Book Value | 1.712 |
Price | 5.17 |
Earnings Yield | -48.74% |